Market Executive Summary
Global siRNA Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.
Demand from Single Gene Rare Disease and Protein Deposition Disease are the major drivers for the industry.
The global research and development of siRNA drugs is still in the development stage of the industry. There are about 300 projects after the global laboratory stage, and the overall development trend is good. Its therapeutic areas are mainly concentrated in tumor, neurology and ophthalmology. Since siRNA has a larger molecular weight and stronger charge than ASO, it is more difficult for siRNA to enter cells by itself, so siRNA drugs have higher requirements for carriers, which is why siRNA drugs are approved later than ASO drugs big reason.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.
Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global siRNA Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
Segment by Type
Givlaari
Patisiran
Givosiran
Segment by Application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the siRNA Drug market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of siRNA Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the siRNA Drug industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of siRNA Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, siRNA Drug introduction, etc. siRNA Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: Conclusions of siRNA Drug market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted.
Table of Contents
1 siRNA Drug Market Overview
1.1 siRNA Drug Product Overview
1.2 siRNA Drug Market Segment by Type
1.2.1 Givlaari
1.2.2 Patisiran
1.2.3 Givosiran
1.3 Global siRNA Drug Market Size by Type
1.3.1 Global siRNA Drug Market Size Overview by Type (2018-2029)
1.3.2 Global siRNA Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global siRNA Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America siRNA Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe siRNA Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific siRNA Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America siRNA Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa siRNA Drug Sales Breakdown by Type (2018-2023)
2 Global siRNA Drug Market Competition by Company
2.1 Global Top Players by siRNA Drug Sales (2018-2023)
2.2 Global Top Players by siRNA Drug Revenue (2018-2023)
2.3 Global Top Players by siRNA Drug Price (2018-2023)
2.4 Global Top Manufacturers siRNA Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 siRNA Drug Market Competitive Situation and Trends
2.5.1 siRNA Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by siRNA Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in siRNA Drug as of 2022)
2.7 Date of Key Manufacturers Enter into siRNA Drug Market
2.8 Key Manufacturers siRNA Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 siRNA Drug Status and Outlook by Region
3.1 Global siRNA Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global siRNA Drug Historic Market Size by Region
3.2.1 Global siRNA Drug Sales in Volume by Region (2018-2023)
3.2.2 Global siRNA Drug Sales in Value by Region (2018-2023)
3.2.3 Global siRNA Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global siRNA Drug Forecasted Market Size by Region
3.3.1 Global siRNA Drug Sales in Volume by Region (2024-2029)
3.3.2 Global siRNA Drug Sales in Value by Region (2024-2029)
3.3.3 Global siRNA Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global siRNA Drug by Application
4.1 siRNA Drug Market Segment by Application
4.1.1 Single Gene Rare Disease
4.1.2 Protein Deposition Disease
4.1.3 Chronic Liver Disease
4.1.4 Others
4.2 Global siRNA Drug Market Size by Application
4.2.1 Global siRNA Drug Market Size Overview by Application (2018-2029)
4.2.2 Global siRNA Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global siRNA Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America siRNA Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe siRNA Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific siRNA Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America siRNA Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa siRNA Drug Sales Breakdown by Application (2018-2023)
5 North America siRNA Drug by Country
5.1 North America siRNA Drug Historic Market Size by Country
5.1.1 North America siRNA Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America siRNA Drug Sales in Volume by Country (2018-2023)
5.1.3 North America siRNA Drug Sales in Value by Country (2018-2023)
5.2 North America siRNA Drug Forecasted Market Size by Country
5.2.1 North America siRNA Drug Sales in Volume by Country (2024-2029)
5.2.2 North America siRNA Drug Sales in Value by Country (2024-2029)
6 Europe siRNA Drug by Country
6.1 Europe siRNA Drug Historic Market Size by Country
6.1.1 Europe siRNA Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe siRNA Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe siRNA Drug Sales in Value by Country (2018-2023)
6.2 Europe siRNA Drug Forecasted Market Size by Country
6.2.1 Europe siRNA Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe siRNA Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific siRNA Drug by Region
7.1 Asia-Pacific siRNA Drug Historic Market Size by Region
7.1.1 Asia-Pacific siRNA Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific siRNA Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific siRNA Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific siRNA Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific siRNA Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific siRNA Drug Sales in Value by Region (2024-2029)
8 Latin America siRNA Drug by Country
8.1 Latin America siRNA Drug Historic Market Size by Country
8.1.1 Latin America siRNA Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America siRNA Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America siRNA Drug Sales in Value by Country (2018-2023)
8.2 Latin America siRNA Drug Forecasted Market Size by Country
8.2.1 Latin America siRNA Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America siRNA Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa siRNA Drug by Country
9.1 Middle East and Africa siRNA Drug Historic Market Size by Country
9.1.1 Middle East and Africa siRNA Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa siRNA Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa siRNA Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa siRNA Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa siRNA Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa siRNA Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Genzyme
10.1.1 Genzyme Company Information
10.1.2 Genzyme Introduction and Business Overview
10.1.3 Genzyme siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Genzyme siRNA Drug Products Offered
10.1.5 Genzyme Recent Development
10.2 Alnylam
10.2.1 Alnylam Company Information
10.2.2 Alnylam Introduction and Business Overview
10.2.3 Alnylam siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alnylam siRNA Drug Products Offered
10.2.5 Alnylam Recent Development
10.3 Dicerna
10.3.1 Dicerna Company Information
10.3.2 Dicerna Introduction and Business Overview
10.3.3 Dicerna siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Dicerna siRNA Drug Products Offered
10.3.5 Dicerna Recent Development
10.4 Quark Pharmaceuticals
10.4.1 Quark Pharmaceuticals Company Information
10.4.2 Quark Pharmaceuticals Introduction and Business Overview
10.4.3 Quark Pharmaceuticals siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Quark Pharmaceuticals siRNA Drug Products Offered
10.4.5 Quark Pharmaceuticals Recent Development
10.5 Arrowhead
10.5.1 Arrowhead Company Information
10.5.2 Arrowhead Introduction and Business Overview
10.5.3 Arrowhead siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Arrowhead siRNA Drug Products Offered
10.5.5 Arrowhead Recent Development
10.6 Exicure
10.6.1 Exicure Company Information
10.6.2 Exicure Introduction and Business Overview
10.6.3 Exicure siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Exicure siRNA Drug Products Offered
10.6.5 Exicure Recent Development
10.7 Miragen Therapeutics
10.7.1 Miragen Therapeutics Company Information
10.7.2 Miragen Therapeutics Introduction and Business Overview
10.7.3 Miragen Therapeutics siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Miragen Therapeutics siRNA Drug Products Offered
10.7.5 Miragen Therapeutics Recent Development
10.8 Silence
10.8.1 Silence Company Information
10.8.2 Silence Introduction and Business Overview
10.8.3 Silence siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Silence siRNA Drug Products Offered
10.8.5 Silence Recent Development
10.9 Sylentis
10.9.1 Sylentis Company Information
10.9.2 Sylentis Introduction and Business Overview
10.9.3 Sylentis siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sylentis siRNA Drug Products Offered
10.9.5 Sylentis Recent Development
10.10 Avidity Biosciences
10.10.1 Avidity Biosciences Company Information
10.10.2 Avidity Biosciences Introduction and Business Overview
10.10.3 Avidity Biosciences siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Avidity Biosciences siRNA Drug Products Offered
10.10.5 Avidity Biosciences Recent Development
10.11 Dicerna
10.11.1 Dicerna Company Information
10.11.2 Dicerna Introduction and Business Overview
10.11.3 Dicerna siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Dicerna siRNA Drug Products Offered
10.11.5 Dicerna Recent Development
10.12 BioNTech
10.12.1 BioNTech Company Information
10.12.2 BioNTech Introduction and Business Overview
10.12.3 BioNTech siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BioNTech siRNA Drug Products Offered
10.12.5 BioNTech Recent Development
10.13 Moderna Therapeutics
10.13.1 Moderna Therapeutics Company Information
10.13.2 Moderna Therapeutics Introduction and Business Overview
10.13.3 Moderna Therapeutics siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Moderna Therapeutics siRNA Drug Products Offered
10.13.5 Moderna Therapeutics Recent Development
10.14 The WhiteOak Group, Inc.
10.14.1 The WhiteOak Group, Inc. Company Information
10.14.2 The WhiteOak Group, Inc. Introduction and Business Overview
10.14.3 The WhiteOak Group, Inc. siRNA Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 The WhiteOak Group, Inc. siRNA Drug Products Offered
10.14.5 The WhiteOak Group, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 siRNA Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 siRNA Drug Industrial Chain Analysis
11.4 siRNA Drug Market Dynamics
11.4.1 siRNA Drug Industry Trends
11.4.2 siRNA Drug Market Drivers
11.4.3 siRNA Drug Market Challenges
11.4.4 siRNA Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 siRNA Drug Distributors
12.3 siRNA Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Major Company of Givlaari
Table 2. Major Company of Patisiran
Table 3. Major Company of Givosiran
Table 4. Global siRNA Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global siRNA Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global siRNA Drug Sales Market Share in Volume by Type (2018-2023)
Table 7. Global siRNA Drug Sales by Type (2018-2023) & (US& Million)
Table 8. Global siRNA Drug Market Share in Value by Type (2018-2023)
Table 9. Global siRNA Drug Price by Type (2018-2023) & (US$/Unit)
Table 10. Global siRNA Drug Sales by Type (2024-2029) & (K Units)
Table 11. Global siRNA Drug Sales Market Share in Volume by Type (2024-2029)
Table 12. Global siRNA Drug Sales by Type (2024-2029) & (US$ Million)
Table 13. Global siRNA Drug Sales Market Share in Value by Type (2024-2029)
Table 14. Global siRNA Drug Price by Type (2024-2029) & (US$/Unit)
Table 15. North America siRNA Drug Sales by Type (2018-2023) & (K Units)
Table 16. North America siRNA Drug Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe siRNA Drug Sales (K Units) by Type (2018-2023)
Table 18. Europe siRNA Drug Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific siRNA Drug Sales (K Units) by Type (2018-2023)
Table 20. Asia-Pacific siRNA Drug Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America siRNA Drug Sales (K Units) by Type (2018-2023)
Table 22. Latin America siRNA Drug Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa siRNA Drug Sales (K Units) by Type (2018-2023)
Table 24. Middle East and Africa siRNA Drug Sales by Type (2018-2023) & (US$ Million)
Table 25. Global siRNA Drug Sales by Company (2018-2023) & (K Units)
Table 26. Global siRNA Drug Sales Share by Company (2018-2023)
Table 27. Global siRNA Drug Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global siRNA Drug Revenue Share by Company (2018-2023)
Table 29. Global Market siRNA Drug Price by Company (2018-2023) & (US$/Unit)
Table 30. Global siRNA Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global siRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in siRNA Drug as of 2022)
Table 33. Date of Key Manufacturers Enter into siRNA Drug Market
Table 34. Key Manufacturers siRNA Drug Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global siRNA Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global siRNA Drug Sales by Region (2018-2023) & (K Units)
Table 38. Global siRNA Drug Sales Market Share in Volume by Region (2018-2023)
Table 39. Global siRNA Drug Sales by Region (2018-2023) & (US$ Million)
Table 40. Global siRNA Drug Sales Market Share in Value by Region (2018-2023)
Table 41. Global siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 42. Global siRNA Drug Sales by Region (2024-2029) & (K Units)
Table 43. Global siRNA Drug Sales Market Share in Volume by Region (2024-2029)
Table 44. Global siRNA Drug Sales by Region (2024-2029) & (US$ Million)
Table 45. Global siRNA Drug Sales Market Share in Value by Region (2024-2029)
Table 46. Global siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global siRNA Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global siRNA Drug Sales by Application (2018-2023) & (K Units)
Table 49. Global siRNA Drug Sales Market Share in Volume by Application (2018-2023)
Table 50. Global siRNA Drug Sales by Application (2018-2023) & (US$ Million)
Table 51. Global siRNA Drug Sales Market Share in Value by Application (2018-2023)
Table 52. Global siRNA Drug Price by Application (2018-2023) & (US$/Unit)
Table 53. Global siRNA Drug Sales by Application (2024-2029) & (K Units)
Table 54. Global siRNA Drug Sales Market Share in Volume by Application (2024-2029)
Table 55. Global siRNA Drug Sales by Application (2024-2029) & (US$ Million)
Table 56. Global siRNA Drug Sales Market Share in Value by Application (2024-2029)
Table 57. Global siRNA Drug Price by Application (2024-2029) & (US$/Unit)
Table 58. North America siRNA Drug Sales by Application (2018-2023) (K Units)
Table 59. North America siRNA Drug Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe siRNA Drug Sales by Application (2018-2023) (K Units)
Table 61. Europe siRNA Drug Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific siRNA Drug Sales by Application (2018-2023) (K Units)
Table 63. Asia-Pacific siRNA Drug Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America siRNA Drug Sales by Application (2018-2023) (K Units)
Table 65. Latin America siRNA Drug Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa siRNA Drug Sales by Application (2018-2023) (K Units)
Table 67. Middle East and Africa siRNA Drug Sales by Application (2018-2023) & (US$ Million)
Table 68. North America siRNA Drug Sales by Country (2018-2023) & (K Units)
Table 69. North America siRNA Drug Sales Market Share in Volume by Country (2018-2023)
Table 70. North America siRNA Drug Sales by Country (2018-2023) & (US$ Million)
Table 71. North America siRNA Drug Sales Market Share in Value by Country (2018-2023)
Table 72. North America siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 73. North America siRNA Drug Sales Market Share in Volume by Country (2024-2029)
Table 74. North America siRNA Drug Sales by Country (2024-2029) & (US$ Million)
Table 75. North America siRNA Drug Sales Market Share in Value by Country (2024-2029)
Table 76. Europe siRNA Drug Sales by Country (2018-2023) & (K Units)
Table 77. Europe siRNA Drug Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe siRNA Drug Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe siRNA Drug Sales Market Share in Value by Country (2018-2023)
Table 80. Europe siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 81. Europe siRNA Drug Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe siRNA Drug Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe siRNA Drug Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific siRNA Drug Sales by Region (2018-2023) & (K Units)
Table 85. Asia-Pacific siRNA Drug Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific siRNA Drug Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific siRNA Drug Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific siRNA Drug Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific siRNA Drug Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific siRNA Drug Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific siRNA Drug Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America siRNA Drug Sales by Country (2018-2023) & (K Units)
Table 93. Latin America siRNA Drug Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America siRNA Drug Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America siRNA Drug Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 97. Latin America siRNA Drug Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America siRNA Drug Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America siRNA Drug Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa siRNA Drug Sales by Country (2018-2023) & (K Units)
Table 101. Middle East and Africa siRNA Drug Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa siRNA Drug Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa siRNA Drug Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa siRNA Drug Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa siRNA Drug Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa siRNA Drug Sales Market Share in Value by Country (2024-2029)
Table 108. Genzyme Company Information
Table 109. Genzyme Introduction and Business Overview
Table 110. Genzyme siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Genzyme siRNA Drug Product
Table 112. Genzyme Recent Development
Table 113. Alnylam Company Information
Table 114. Alnylam Introduction and Business Overview
Table 115. Alnylam siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Alnylam siRNA Drug Product
Table 117. Alnylam Recent Development
Table 118. Dicerna Company Information
Table 119. Dicerna Introduction and Business Overview
Table 120. Dicerna siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Dicerna siRNA Drug Product
Table 122. Dicerna Recent Development
Table 123. Quark Pharmaceuticals Company Information
Table 124. Quark Pharmaceuticals Introduction and Business Overview
Table 125. Quark Pharmaceuticals siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Quark Pharmaceuticals siRNA Drug Product
Table 127. Quark Pharmaceuticals Recent Development
Table 128. Arrowhead Company Information
Table 129. Arrowhead Introduction and Business Overview
Table 130. Arrowhead siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Arrowhead siRNA Drug Product
Table 132. Arrowhead Recent Development
Table 133. Exicure Company Information
Table 134. Exicure Introduction and Business Overview
Table 135. Exicure siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Exicure siRNA Drug Product
Table 137. Exicure Recent Development
Table 138. Miragen Therapeutics Company Information
Table 139. Miragen Therapeutics Introduction and Business Overview
Table 140. Miragen Therapeutics siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Miragen Therapeutics siRNA Drug Product
Table 142. Miragen Therapeutics Recent Development
Table 143. Silence Company Information
Table 144. Silence Introduction and Business Overview
Table 145. Silence siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Silence siRNA Drug Product
Table 147. Silence Recent Development
Table 148. Sylentis Company Information
Table 149. Sylentis Introduction and Business Overview
Table 150. Sylentis siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Sylentis siRNA Drug Product
Table 152. Sylentis Recent Development
Table 153. Avidity Biosciences Company Information
Table 154. Avidity Biosciences Introduction and Business Overview
Table 155. Avidity Biosciences siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Avidity Biosciences siRNA Drug Product
Table 157. Avidity Biosciences Recent Development
Table 158. Dicerna Company Information
Table 159. Dicerna Introduction and Business Overview
Table 160. Dicerna siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Dicerna siRNA Drug Product
Table 162. Dicerna Recent Development
Table 163. BioNTech Company Information
Table 164. BioNTech Introduction and Business Overview
Table 165. BioNTech siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. BioNTech siRNA Drug Product
Table 167. BioNTech Recent Development
Table 168. Moderna Therapeutics Company Information
Table 169. Moderna Therapeutics Introduction and Business Overview
Table 170. Moderna Therapeutics siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Moderna Therapeutics siRNA Drug Product
Table 172. Moderna Therapeutics Recent Development
Table 173. The WhiteOak Group, Inc. Company Information
Table 174. The WhiteOak Group, Inc. Introduction and Business Overview
Table 175. The WhiteOak Group, Inc. siRNA Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. The WhiteOak Group, Inc. siRNA Drug Product
Table 177. The WhiteOak Group, Inc. Recent Development
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. siRNA Drug Market Trends
Table 181. siRNA Drug Market Drivers
Table 182. siRNA Drug Market Challenges
Table 183. siRNA Drug Market Restraints
Table 184. siRNA Drug Distributors List
Table 185. siRNA Drug Downstream Customers
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. siRNA Drug Product Picture
Figure 2. Global siRNA Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global siRNA Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global siRNA Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Givlaari
Figure 6. Global Givlaari Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Patisiran
Figure 8. Global Patisiran Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Givosiran
Figure 10. Global Givosiran Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global siRNA Drug Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global siRNA Drug Sales Market Share by Type in 2022 & 2029
Figure 13. North America siRNA Drug Sales Market Share in Volume by Type in 2022
Figure 14. North America siRNA Drug Sales Market Share in Value by Type in 2022
Figure 15. Europe siRNA Drug Sales Market Share in Volume by Type in 2022
Figure 16. Europe siRNA Drug Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific siRNA Drug Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific siRNA Drug Sales Market Share in Value by Type in 2022
Figure 19. Latin America siRNA Drug Sales Market Share in Volume by Type in 2022
Figure 20. Latin America siRNA Drug Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa siRNA Drug Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa siRNA Drug Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by siRNA Drug Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by siRNA Drug Revenue in 2022
Figure 25. siRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Single Gene Rare Disease
Figure 27. Global Single Gene Rare Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Protein Deposition Disease
Figure 29. Global Protein Deposition Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Chronic Liver Disease
Figure 31. Global Chronic Liver Disease Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global siRNA Drug Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global siRNA Drug Sales Market Share by Application in 2022 & 2029
Figure 36. North America siRNA Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America siRNA Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe siRNA Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe siRNA Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific siRNA Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific siRNA Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America siRNA Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America siRNA Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa siRNA Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. siRNA Drug Manufacturing Cost Structure
Figure 47. siRNA Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
